43 related articles for article (PubMed ID: 14632312)
1. Association of SH2-B to phosphorylated tyrosine residues in the activation loop of TrkB.
Suzuki K; Mizutani M; Hitomi Y; Kizaki T; Ohno H; Ishida H; Haga S; Koizumi S
Res Commun Mol Pathol Pharmacol; 2002; 111(1-4):27-39. PubMed ID: 14632312
[TBL] [Abstract][Full Text] [Related]
2. The protein tyrosine phosphatase, Shp2, is required for the complete activation of the RAS/MAPK pathway by brain-derived neurotrophic factor.
Easton JB; Royer AR; Middlemas DS
J Neurochem; 2006 May; 97(3):834-45. PubMed ID: 16573649
[TBL] [Abstract][Full Text] [Related]
3. The N-terminal SH2 domain of the tyrosine phosphatase, SHP-2, is essential for Jak2-dependent signaling via the angiotensin II type AT1 receptor.
Godeny MD; Sayyah J; VonDerLinden D; Johns M; Ostrov DA; Caldwell-Busby J; Sayeski PP
Cell Signal; 2007 Mar; 19(3):600-9. PubMed ID: 17027227
[TBL] [Abstract][Full Text] [Related]
4. PSM/SH2-B distributes selected mitogenic receptor signals to distinct components in the PI3-kinase and MAP kinase signaling pathways.
Deng Y; Xu H; Riedel H
J Cell Biochem; 2007 Feb; 100(3):557-73. PubMed ID: 16960871
[TBL] [Abstract][Full Text] [Related]
5. IREM-1 is a novel inhibitory receptor expressed by myeloid cells.
Alvarez-Errico D; Aguilar H; Kitzig F; Brckalo T; Sayós J; López-Botet M
Eur J Immunol; 2004 Dec; 34(12):3690-701. PubMed ID: 15549731
[TBL] [Abstract][Full Text] [Related]
6. Activation loop phosphorylation-independent kinase activity of human protein kinase C zeta.
Ranganathan S; Wang Y; Kern FG; Qu Z; Li R
Proteins; 2007 May; 67(3):709-19. PubMed ID: 17335005
[TBL] [Abstract][Full Text] [Related]
7. Alternative mode of binding to phosphotyrosyl peptides by Src homology-2 domains.
Qin C; Wavreille AS; Pei D
Biochemistry; 2005 Sep; 44(36):12196-202. PubMed ID: 16142918
[TBL] [Abstract][Full Text] [Related]
8. A rare mRNA variant of the human lymphocyte-specific protein tyrosine kinase LCK gene with intron B retention and exon 7 skipping encodes a putative protein with altered SH3-dependent molecular interactions.
Nervi S; Guinamard R; Delaval B; Lécine P; Vialettes B; Naquet P; Imbert J
Gene; 2005 Oct; 359():18-25. PubMed ID: 16107303
[TBL] [Abstract][Full Text] [Related]
9. Rak, a novel nuclear tyrosine kinase expressed in epithelial cells.
Cance WG; Craven RJ; Bergman M; Xu L; Alitalo K; Liu ET
Cell Growth Differ; 1994 Dec; 5(12):1347-55. PubMed ID: 7696183
[TBL] [Abstract][Full Text] [Related]
10. SH2 domains: role, structure and implications for molecular medicine.
Waksman G; Kumaran S; Lubman O
Expert Rev Mol Med; 2004 Jan; 6(3):1-18. PubMed ID: 14987415
[TBL] [Abstract][Full Text] [Related]
11. Workshop cluster 1, a gammadelta T cell specific receptor is phosphorylated and down regulated by activation induced Src family kinase activity.
Pillai MR; Lefevre EA; Carr BV; Charleston B; O'Grady P
Mol Immunol; 2007 Mar; 44(7):1691-703. PubMed ID: 16997376
[TBL] [Abstract][Full Text] [Related]
12. Characterization of inhibitory signaling motifs of the natural killer cell receptor Siglec-7: attenuated recruitment of phosphatases by the receptor is attributed to two amino acids in the motifs.
Yamaji T; Mitsuki M; Teranishi T; Hashimoto Y
Glycobiology; 2005 Jul; 15(7):667-76. PubMed ID: 15703304
[TBL] [Abstract][Full Text] [Related]
13. Phosphopeptide ligands of the SHP-1 N-SH2 domain: effects on binding and stimulation of phosphatase activity.
Hampel K; Kaufhold I; Zacharias M; Böhmer FD; Imhof D
ChemMedChem; 2006 Aug; 1(8):869-77. PubMed ID: 16902940
[TBL] [Abstract][Full Text] [Related]
14. Dd-STATb, a Dictyostelium STAT protein with a highly aberrant SH2 domain, functions as a regulator of gene expression during growth and early development.
Zhukovskaya NV; Fukuzawa M; Tsujioka M; Jermyn KA; Kawata T; Abe T; Zvelebil M; Williams JG
Development; 2004 Jan; 131(2):447-58. PubMed ID: 14701681
[TBL] [Abstract][Full Text] [Related]
15. Molecular basis for regulation of Src by the docking protein p130Cas.
Nasertorabi F; Tars K; Becherer K; Kodandapani R; Liljas L; Vuori K; Ely KR
J Mol Recognit; 2006; 19(1):30-8. PubMed ID: 16245368
[TBL] [Abstract][Full Text] [Related]
16. Four PSM/SH2-B alternative splice variants and their differential roles in mitogenesis.
Yousaf N; Deng Y; Kang Y; Riedel H
J Biol Chem; 2001 Nov; 276(44):40940-8. PubMed ID: 11502739
[TBL] [Abstract][Full Text] [Related]
17. Tyrosine phosphorylation of adaptor protein 3BP2 induces T cell receptor-mediated activation of transcription factor.
Qu X; Kawauchi-Kamata K; Miah SM; Hatani T; Yamamura H; Sada K
Biochemistry; 2005 Mar; 44(10):3891-8. PubMed ID: 15751964
[TBL] [Abstract][Full Text] [Related]
18. Structural basis for the inhibition of tyrosine kinase activity of ZAP-70.
Deindl S; Kadlecek TA; Brdicka T; Cao X; Weiss A; Kuriyan J
Cell; 2007 May; 129(4):735-46. PubMed ID: 17512407
[TBL] [Abstract][Full Text] [Related]
19. Alternative splicing, gene localization, and binding of SH2-B to the insulin receptor kinase domain.
Nelms K; O'Neill TJ; Li S; Hubbard SR; Gustafson TA; Paul WE
Mamm Genome; 1999 Dec; 10(12):1160-7. PubMed ID: 10594240
[TBL] [Abstract][Full Text] [Related]
20. ShcD interacts with TrkB via its PTB and SH2 domains and regulates BDNF-induced MAPK activation.
You Y; Li W; Gong Y; Yin B; Qiang B; Yuan J; Peng X
BMB Rep; 2010 Jul; 43(7):485-90. PubMed ID: 20663410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
